Français
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
ovarian neoplasms/œdème
Le lien est enregistré dans le presse-papiers
Page 1 de 129 résultats
[Case report of re-expansion pulmonary edema in a patient with anorexia nervosa after removal of a huge ovarian tumor].
Seuls les utilisateurs enregistrés peuvent traduire des articles
Se connecter S'inscrire
We described a case of 19-year-old female who developed re-expansion pulmonary edema (RPE) after removal of a huge ovarian tumor. Altered lung volume after the surgery was observed by chest X-ray. Preoperatively, the lung was highly compressed by the tumor. Patient was intubated under general
A Giant Ovarian Tumor Causing Anasarca and Dyspnea Successfully Managed after Preoperative Drainage.
Seuls les utilisateurs enregistrés peuvent traduire des articles
Se connecter S'inscrire
Serious complications are likely to accompany the treatment of giant ovarian tumors, and resection with or without preoperative drainage has been previously reported. Here, we report the case of a 27-year-old Japanese woman with a significant weight gain of 50 kg, who was referred to the Kumamoto
Lower extremity edema in patients with early ovarian cancer.
Seuls les utilisateurs enregistrés peuvent traduire des articles
Se connecter S'inscrire
BACKGROUND
The objective of this study was to investigate clinical manifestations of lower extremity edema (LEE) in early ovarian cancer.
METHODS
Patients with early ovarian cancer who underwent staging surgery between January 2001 and December 2010. Medical records for LEE and/or responses to the
Cystoid macular edema secondary to paclitaxel therapy for ovarian cancer: A case report.
Seuls les utilisateurs enregistrés peuvent traduire des articles
Se connecter S'inscrire
Paclitaxel is a member of the taxane agents that has demonstrated efficacy in ovarian cancer, both in first- and in second-line therapy. Counted among the side-effects of this drug are neurological disorders. In the present study, a rare case of a non-neuropathic ocular disorder, known as cystoid
[Bilateral benign enlarged ovarian tumors, ascites and hydrops of the gallbladder--a rare combination].
Seuls les utilisateurs enregistrés peuvent traduire des articles
Se connecter S'inscrire
In this case the unusual combination of an enlarged twisted ovarian cyst, a parovarian cyst, ascites and gall-bladder hydrops is being reported. Literature references regarding the clinical relevance of this problems are given.
[Case of edema in lower extremity after surgery of ovarian cancer].
Seuls les utilisateurs enregistrés peuvent traduire des articles
Se connecter S'inscrire
Dropsy of the Amnion Simulating Ovarian Tumour.
Seuls les utilisateurs enregistrés peuvent traduire des articles
Se connecter S'inscrire
Massive ovarian edema with androgen secretion. A pathological and endocrine study with review of the literature.
Seuls les utilisateurs enregistrés peuvent traduire des articles
Se connecter S'inscrire
A case of massive edema of the left ovary with virilization is described. Microscopically, massive interstitial edema with luteinization of theca and stromal cells was found. A few stromal cells contained Reinke-type crystalloids--an original observation. Peripheral concentrations of testosterone,
Health-related quality of life in women with recurrent ovarian cancer receiving paclitaxel plus trebananib or placebo (TRINOVA-1).
Seuls les utilisateurs enregistrés peuvent traduire des articles
Se connecter S'inscrire
To evaluate the influence of treatment on health-related quality of life (HRQoL) in 919 women with recurrent ovarian cancer enrolled in the TRINOVA-1 study, a randomized, placebo-controlled phase III study that demonstrated that trebananib 15 mg/kg QW plus weekly paclitaxel significantly improved
Bilateral Cystoid Macular Edema Secondary to Paclitaxel Treatment.
Seuls les utilisateurs enregistrés peuvent traduire des articles
Se connecter S'inscrire
Cystoid macular edema is rarely observed secondary to paclitaxel treatment. A 55-year-old female patient was applied five cures of paclitaxel and carboplatin chemotherapy after being diagnosed with metastatic ovarian cancer. The patient had a normal bilateral vision prior to the chemotherapy
Adjuvant intensity modulated whole-abdominal radiation therapy for high-risk patients with ovarian cancer FIGO stage III: final results of a prospective phase 2 study.
Seuls les utilisateurs enregistrés peuvent traduire des articles
Se connecter S'inscrire
Recombinant human interleukin-3 to dose-intensify carboplatin and cyclophosphamide chemotherapy in epithelial ovarian cancer: a phase I trial.
Seuls les utilisateurs enregistrés peuvent traduire des articles
Se connecter S'inscrire
OBJECTIVE
To define the optimal dose of recombinant human interleukin-3 (rhIL-3) required to intensify the dose of carboplatin and cyclophosphamide for advanced epithelial ovarian cancer.
METHODS
Seventeen patients were treated on day 1 with carboplatin (dose adjusted for creatinine clearance:
A prospective analysis of imatinib-induced c-KIT modulation in ovarian cancer: a phase II clinical study with proteomic profiling.
Seuls les utilisateurs enregistrés peuvent traduire des articles
Se connecter S'inscrire
BACKGROUND
c-Kit and platelet-derived growth factor receptor (PDGFR) are potential molecular targets in epithelial ovarian cancer (EOC). Imatinib inhibits the kinase domain and subsequent downstream signaling of these receptor tyrosine kinases. The objective of this study was to investigate
New cytostatic drugs in ovarian cancer.
Seuls les utilisateurs enregistrés peuvent traduire des articles
Se connecter S'inscrire
BACKGROUND
Many ovarian cancer patients will after treatment of the recurrence with cisplatin based therapy enter phase I or II studies with new drugs. Lately, some new agents have shown activity.
METHODS
The review is based on phase II studies mainly and focuses on paclitaxel (taxol).
RESULTS
A
[Docetaxel and carboplatin for epithelial ovarian cancer].
Seuls les utilisateurs enregistrés peuvent traduire des articles
Se connecter S'inscrire
We report herein on the efficacy and toxicity of docetaxel and carboplatin in patients with epithelial ovarian cancer. Fifteen patients with FIGO stage I c-IV epithelial ovarian cancer were administered docetaxel (70 mg/m2) and carboplatin (AUC 5) every 3 weeks as 1 course. Eleven patients received
La base de données d'herbes médicinales la plus complète soutenue par la science
- Fonctionne en 55 langues
- Cures à base de plantes soutenues par la science
- Reconnaissance des herbes par image
- Carte GPS interactive - étiquetez les herbes sur place (à venir)
- Lisez les publications scientifiques liées à votre recherche
- Rechercher les herbes médicinales par leurs effets
- Organisez vos intérêts et restez à jour avec les nouvelles recherches, essais cliniques et brevets
Tapez un symptôme ou une maladie et lisez des informations sur les herbes qui pourraient aider, tapez une herbe et voyez les maladies et symptômes contre lesquels elle est utilisée.
* Toutes les informations sont basées sur des recherches scientifiques publiées
